Could Theralase Technologies Inc. Crash Even More? The Stock Had Another Big Decline Today

 Could Theralase Technologies Inc. Crash Even More? The Stock Had Another Big Decline Today

The stock of Theralase Technologies Inc. (CVE:TLT) is a huge mover today! About 97,650 shares traded hands. Theralase Technologies Inc. (CVE:TLT) has risen 6.00% since October 17, 2016 and is uptrending. It has outperformed by 1.31% the S&P500.
The move comes after 9 months negative chart setup for the $31.53M company. It was reported on Nov, 16 by Barchart.com. We have $0.23 PT which if reached, will make CVE:TLT worth $3.15M less.

More recent Theralase Technologies Inc. (CVE:TLT) news were published by: Midasletter.com which released: “Theralase Technologies Inc: A Cure for Cancer?” on February 24, 2014. Also Business.Financialpost.com published the news titled: “Podcast: Theralase Technologies CEO on using light for pain and cancer treatment” on June 15, 2016. Seekingalpha.com‘s news article titled: “Initiation Report For Theralase Technologies” with publication date: May 09, 2014 was also an interesting one.

Theralase Technologies Inc. is a biotech firm focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds to destroy cancer. The company has a market cap of $31.53 million. The Firm operates through two divisions: Therapeutic Laser Technology (TLT) division and Photo Dynamic Therapy (PDT) division. It currently has negative earnings. The TLT division designs, develops, makes and markets super-pulsed laser technology indicated for the healing of chronic knee pain.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment